Evolent Health, Inc. EVH Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s amortization expense related to capitalized debt issuance costs?
- Evolent Health, Inc. (EVH) reported amortization expense related to capitalized debt issuance costs of $2.95M in Q1 2026.
- How has Evolent Health, Inc.'s amortization expense related to capitalized debt issuance costs changed year-over-year?
- Evolent Health, Inc.'s amortization expense related to capitalized debt issuance costs increased by 155.5% year-over-year, from $1.15M to $2.95M.
- What is the long-term trend for Evolent Health, Inc.'s amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s amortization expense related to capitalized debt issuance costs has grown at a -18.9% compound annual growth rate (CAGR), from $18.05M to $7.8M.